RxDoctor Payments Data

Stephanie Ritari

Physician Assistant · Boise, IDNPI 1730157447

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $5,250 of the $7,664 with a category attached, or 68.5%. ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) accounts for 76.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $3,972 and has fallen 98.0% since, to $79 in 2025. Among physician assistant clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,664in general payments, 2019–2025

Across 51 payments — averaging $150.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$6K
  • Atricure, Inc.$2K
  • Medtronic$138
  • Biotronik Inc.$42
  • Biosense Webster, Inc.$26
  • Pfizer$26
  • plus $92 from 4 others

What the payments were for

  • Speaking & faculty fees$5,25069%
  • Travel & lodging$1,01613%
  • Food & beverage$1,35618%
  • Education$421%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,664 in reported general payments places this provider in the 95th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$73,871
Medicare patients
377
Services billed
1,284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban299$345,513
XareltoRivaroxaban45$51,398
MultaqDronedarone Hcl38$45,856
Dofetilide62$14,530
Metoprolol Succinate433$5,015
Ranolazine ErRanolazine79$4,589
Diltiazem 24hr Er (Cd)Diltiazem Hcl111$3,063
Amiodarone Hcl87$1,899
Digoxin38$978
Potassium Chloride23$477
Verapamil ErVerapamil Hcl14$444
Cartia XtDiltiazem Hcl24$411
Metoprolol Tartrate53$348
SotalolSotalol Hcl13$266
Amlodipine Besylate33$256

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$26$345,513299 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →